The G2385R risk factor for Parkinson’s disease enhances CHIP-dependent intracellular degradation of LRRK2

Documenti analoghi

• Differences in stability, activity and mutation effects between human and mouse Leucine-Rich Repeat Kinase 2
  di: Langston, Rebekah G., et al.
  Pubblicazione: (2018)
• The function of orthologues of the human Parkinson’s disease gene LRRK2 across species: implications for disease modeling in preclinical research
  di: Langston, Rebekah G., et al.
  Pubblicazione: (2016)
• Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
  di: Rudenko, Iakov N, et al.
  Pubblicazione: (2012)
• The G2385R Variant of Leucine-Rich Repeat Kinase 2 Associated with Parkinson's Disease is a Partial Loss of Function Mutation
  di: Rudenko, Iakov N., et al.
  Pubblicazione: (2012)
• Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
  di: Chia, Ruth, et al.
  Pubblicazione: (2014)